$ADTX
Aditxt, Inc. Stock $adtx

$adtx Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067112 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$124.5K	$221.0K	$185.6K
YoY Change	-61.47%	2.92%	76.71%
Cost Of Revenue	$106.9K	$185.7K	$170.2K
YoY Change	-54.25%	6.22%	118.22%
Gross Profit	$17.56K	$35.24K	$15.43K
YoY Change	-80.36%	-11.58%	-42.96%
Gross Profit Margin	14.11%	15.95%	8.31%
Selling, General & Admin	$7.214M	$3.785M	$5.134M
YoY Change	84.45%	353.85%	-77.0%
% of Gross Profit	41072.93%	10740.19%	33274.34%
Research & Development	$898.7K	$484.8K	$3.081M
YoY Change	-42.78%	-59.19%	81.0%
% of Gross Profit	5116.85%	1375.81%	19969.15%
Depreciation & Amortization	$109.6K	$109.9K	$159.0K
YoY Change	-13.52%	10.07%	22.51%
% of Gross Profit	624.07%	311.87%	1030.72%
Operating Expenses	$8.113M	$4.270M	$8.215M
YoY Change	48.0%	111.18%	-65.8%
Operating Profit	-$8.095M	-$4.234M	-$8.200M
YoY Change	50.13%	-26.63%	-65.82%
Interest Expense	-$1.651M	-$1.448M	$16.88K
YoY Change	-23.77%	1731.22%	-128.71%
% of Operating Profit
Other Income/Expense, Net	-$1.651M	-$1.448M	$0.00
YoY Change	-23.77%	1731.25%
Pretax Income	-$9.746M	-$5.682M	-$8.183M
YoY Change	28.96%	-2.87%	-65.98%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$9.746M	-$5.682M	-$8.183M
YoY Change	28.96%	-2.87%	-65.98%
Net Earnings / Revenue	-7828.91%	-2571.3%	-4409.04%
Basic Earnings Per Share	-$48.77	-$0.92
Diluted Earnings Per Share	-$47.95	-$0.93	-$1.96
COMMON SHARES
Basic Shares Outstanding	7.611M shares	4.833M shares	4.161M shares
Diluted Shares Outstanding	203.2K shares	6.178M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.651M	$95.95K	$2.769M
YoY Change	-82.14%	-88.07%	-64.83%
Cash & Equivalents	$1.651M	$95.95K	$2.769M
Short-Term Investments
Other Short-Term Assets	$555.6K	$654.0K	$496.9K
YoY Change	-19.41%	10.76%	7.99%
Inventory	$858.1K	$1.018M	$950.1K
Prepaid Expenses	$555.6K	$654.0K	$496.9K
Receivables	$362.7K	$379.2K	$528.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.428M	$2.148M	$4.744M
YoY Change	-72.85%	-40.97%	-49.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.004M	$2.104M	$2.319M
YoY Change	-10.89%	-10.26%	2.27%
Goodwill
YoY Change
Intangibles	$26.75K		$107.0K
YoY Change
Long-Term Investments	$312.3K	$287.3K	$355.4K
YoY Change	-21.56%	-30.08%	-6.3%
Other Assets	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$4.798M	$5.146M	$5.992M
YoY Change	-26.81%	-27.54%	-17.32%
TOTAL ASSETS
Total Short-Term Assets	$3.428M	$2.148M	$4.744M
Total Long-Term Assets	$4.798M	$5.146M	$5.992M
Total Assets	$8.226M	$7.294M	$10.74M
YoY Change	-57.11%	-32.09%	-35.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.224M	$5.398M	$1.959M
YoY Change	55.77%	12.15%	24.31%
Accrued Expenses	$1.081M	$1.103M	$1.087M
YoY Change	-3.69%	-2.46%	-5.11%
Deferred Revenue
YoY Change
Short-Term Debt	$4.020M	$2.916M	$0.00
YoY Change	4925.08%	525.94%
Long-Term Debt Due	$147.8K	$147.8K	$410.0K
YoY Change	-40.09%	-66.28%	-41.47%
Total Short-Term Liabilities	$11.24M	$9.744M	$3.644M
YoY Change	157.1%	38.39%	1.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.204M	$1.419M	$1.885M
YoY Change	-43.01%	-39.29%	-31.84%
Total Long-Term Liabilities	$1.204M	$1.419M	$1.885M
YoY Change	-43.01%	-39.29%	-34.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.24M	$9.744M	$3.644M
Total Long-Term Liabilities	$1.204M	$1.419M	$1.885M
Total Liabilities	$12.45M	$11.16M	$5.529M
YoY Change	91.92%	19.03%	-14.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$116.6M	-$106.7M	-$95.04M
YoY Change	34.31%	34.63%	41.11%
Common Stock	$368.00	$6.764K	$4.307K
YoY Change	-90.14%	-87.81%	-90.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$201.6K	$201.6K	$201.6K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares			2.017K shares
Shareholders Equity	-$4.222M	-$3.869M	$5.206M
YoY Change
Total Liabilities & Shareholders Equity	$8.226M	$7.294M	$10.74M
YoY Change	-57.11%	-32.09%	-35.58%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$9.746M	-$5.682M	-$8.183M
YoY Change	28.96%	-2.87%	-65.98%
Depreciation, Depletion And Amortization	$109.6K	$109.9K	$159.0K
YoY Change	-13.52%	10.07%	22.51%
Cash From Operating Activities	-$8.038M	-$3.282M	-$6.720M
YoY Change	2.8%	23.64%	-22.68%
INVESTING ACTIVITIES
Capital Expenditures	$4.410K	$0.00	$88.82K
YoY Change	-205.25%	-100.0%	-177.19%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$268.5K
YoY Change	-100.0%	-100.0%	-103.21%
Cash From Investing Activities	-$4.410K	$0.00	$179.7K
YoY Change	-105.04%	-100.0%	-102.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.595M	3.075M	64.01K
YoY Change	-40.67%	107.96%	-99.67%
NET CHANGE
Cash From Operating Activities	-8.038M	-3.282M	-6.720M
Cash From Investing Activities	-4.410K	0.000	179.7K
Cash From Financing Activities	9.595M	3.075M	64.01K
Net Change In Cash	1.553M	-206.6K	-6.476M
YoY Change	-81.6%	-84.25%	-369.55%
FREE CASH FLOW
Cash From Operating Activities	-$8.038M	-$3.282M	-$6.720M
Capital Expenditures	$4.410K	$0.00	$88.82K
Free Cash Flow	-$8.042M	-$3.282M	-$6.809M
YoY Change	2.91%	29.82%	-20.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.42
CY2023Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	adtx	Stock Issued During Period Value Issuance Of Shares For Vested Restricted Stock Units StockIssuedDuringPeriodValueIssuanceOfSharesForVestedRestrictedStockUnits		usd
CY2022Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39336
	dei	Entity Registrant Name EntityRegistrantName	Aditxt, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3204328
	dei	Entity Address Address Line1 EntityAddressAddressLine1	737 N. Fifth Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richmond
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23219
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	870-1200
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	ADTX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7610739	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95953	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2768640	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	379166	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	527961	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1018493	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950093	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	653954	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	496869	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2147566	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4743563	usd
CY2023Q2	adtx	Fixed Asset FixedAsset	2104114	usd
CY2022Q4	adtx	Fixed Asset FixedAsset	2318863	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	53500	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	107000	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	287265	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	355366	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2701338	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3160457	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	50000	usd
CY2023Q2	us-gaap	Assets Assets	7293783	usd
CY2022Q4	us-gaap	Assets Assets	10735249	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5397931	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1958502	usd
CY2023Q2	adtx	Notes Payable Net Of Discount NotesPayableNetOfDiscount	2615946	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	300000	usd
CY2023Q2	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm	147823	usd
CY2022Q4	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm	409983	usd
CY2023Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	179302	usd
CY2022Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	188581	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1102779	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1086658	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9743781	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3643724	usd
CY2023Q2	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	1419257	usd
CY2022Q4	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	1885218	usd
CY2023Q2	us-gaap	Liabilities Liabilities	11163038	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5528942	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6763750	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4307487	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6761733	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4305470	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	6764	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4307	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2017	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2017	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	103032672	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100443967	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106707086	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95040362	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3869255	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5206307	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7293783	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10735249	usd
CY2023Q2	us-gaap	Revenues Revenues	220978	usd
CY2022Q2	us-gaap	Revenues Revenues	214715	usd
	us-gaap	Revenues Revenues	439393	usd
	us-gaap	Revenues Revenues	424994	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	185738	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	174858	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	364047	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	362929	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	35240	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	39857	usd
	us-gaap	Gross Profit GrossProfit	75346	usd
	us-gaap	Gross Profit GrossProfit	62065	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3671083	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3788952	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8039926	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8413110	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	484835	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1187920	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1872376	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2616302	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	113759	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	833942	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	179376	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	920541	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4269677	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5810814	usd
	us-gaap	Operating Expenses OperatingExpenses	10091678	usd
	us-gaap	Operating Expenses OperatingExpenses	11949953	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4234437	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5770957	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10016332	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11887888	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	1285031	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	82110	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1483523	usd
	us-gaap	Interest Expense Other InterestExpenseOther	97320	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	343	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	6007	usd
	us-gaap	Interest Income Other InterestIncomeOther	9417	usd
	us-gaap	Interest Income Other InterestIncomeOther	20047	usd
	us-gaap	Other Income OtherIncome	58960	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	162893	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2946	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	176286	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2946	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1447581	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79049	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1650392	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21259	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5682018	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5850006	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11666724	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11909147	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5682018	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5850006	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11666724	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11909147	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.21
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6177857	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	911213	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5374826	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	901468	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5206307	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	59964	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	111187	usd
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	507016	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	168300	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5984706	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	68068	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	59964	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	103264	usd
CY2023Q2	adtx	Warrants Issued For Cash Net Of Issuance Costs WarrantsIssuedForCashNetOfIssuanceCosts	1581467	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5682018	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3869255	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	219885	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	377671	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3719	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6059141	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4722907	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	724584	usd
CY2022Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1203769	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	250000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5850006	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1360958	usd
	us-gaap	Profit Loss ProfitLoss	-11666724	usd
	us-gaap	Profit Loss ProfitLoss	-11909147	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	502679	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1885563	usd
	us-gaap	Depreciation Depreciation	219800	usd
	us-gaap	Depreciation Depreciation	196704	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53500	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53500	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	176286	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2946	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-148795	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	320749	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	157085	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	130316	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	-68101	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	31587	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	68400	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	838198	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3489429	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3237681	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7233619	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7853603	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	5051	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	274073	usd
	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	215173	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	19836	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5051	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-509082	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	687523	usd
	adtx	Write Off Of Deferred Offering Costs WriteOffOfDeferredOfferingCosts	-3433410	usd
	adtx	Write Off Of Deferred Offering Costs WriteOffOfDeferredOfferingCosts	-550000	usd
	adtx	Discount On Note Payable From Offering Costs DiscountOnNotePayableFromOfferingCosts	-16500	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	387523	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	993750	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	70598	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1581467	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	507016	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1203769	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	262160	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	372076	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4565983	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1294595	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2672687	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7068090	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2768640	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7872061	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95953	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	803971	usd
	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	1524544	usd
	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	70831	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91667	shares
CY2021Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	120
	adtx	Stockholders Equity Other Share StockholdersEquityOtherShare	375	shares
CY2021Q3	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	11000000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	91667	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	75
CY2021Q3	adtx	Purchase Of Common Stock PurchaseOfCommonStock	4584	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56667	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	75
CY2021Q4	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	4250000	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	3910000	usd
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	16000000	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164929	shares
CY2021Q4	adtx	Prefunded Warrants Shares PrefundedWarrantsShares	166572	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	57.5
CY2021Q4	adtx	Prefunded Warrants Exercise Price PrefundedWarrantsExercisePrice	0.001
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	17200000	usd
CY2022Q3	adtx	Purchase Of Equity Shares PurchaseOfEquityShares	2109000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	3333333	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6
CY2022Q3	adtx	Prefunded Warrants Exercise Price PrefundedWarrantsExercisePrice	0.001
CY2023Q2	adtx	Purchase Of Common Stock Shares Issued PurchaseOfCommonStockSharesIssued	1585350	shares
CY2023Q2	adtx	Warrant Purchase Price WarrantPurchasePrice	1.219
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.86
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95121	shares
CY2023Q2	adtx	Exercise Price Per Share ExercisePricePerShare	1.525
	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	1900000	usd
	adtx	Net Loss Cash Flow From Operating Activities NetLossCashFlowFromOperatingActivities	11666724	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	7233619	usd
CY2023Q2	us-gaap	Cash Cash	95953	usd
CY2023Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	75000000	usd
CY2023Q1	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	2500000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	500000	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	248813	usd
	us-gaap	Sale Leaseback Transaction Other Payments Required SaleLeasebackTransactionOtherPaymentsRequired	25000	usd
	adtx	Payment Of Milestone Fees PaymentOfMilestoneFees	50000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Significant estimates underlying the financial statements include the collectability of notes receivable, collectability and reserve on accounts receivable, the reserve on insurance billing, and the fair value of stock options and warrants.</span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Substantially all the Company’s accounts receivable are with companies in the healthcare industry, individuals, and the U.S. government. However, concentration of credit risk is mitigated due to the Company’s number of customers. In addition, for receivables due from U.S. government agencies, the Company does not believe the receivables represent a credit risk as these are related to healthcare programs funded by the U.S. government and payment is primarily dependent upon submitting the appropriate documentation.</span></p>
CY2021Q1	us-gaap	Derivative Average Cap Interest Rate DerivativeAverageCapInterestRate	0.08	pure
	us-gaap	Clearance Fees ClearanceFees	25000	usd
CY2020Q2	us-gaap	Financial Guarantee Insurance Contracts Accelerated Premium Revenue Amount FinancialGuaranteeInsuranceContractsAcceleratedPremiumRevenueAmount	10000000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	18634	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	74525	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1872376	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2616302	usd
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	44712	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2603	shares
	adtx	Dilutive Earning Shares DilutiveEarningShares	7903748	shares
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	2235466	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	865900	shares
	adtx	Warrants Exercised Shares WarrantsExercisedShares	45963691	shares
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3139901	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1035787	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2104114	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3134850	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	815987	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2318863	usd
CY2023Q2	us-gaap	Depreciation Depreciation	109904	usd
CY2022Q2	us-gaap	Depreciation Depreciation	99852	usd
	us-gaap	Depreciation Depreciation	219800	usd
	us-gaap	Depreciation Depreciation	196704	usd
CY2023Q2	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1316830	usd
CY2022Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1359091	usd
CY2020Q4	us-gaap	Equipment Expense EquipmentExpense	19487	usd
CY2020Q4	us-gaap	Derivative Average Cap Interest Rate DerivativeAverageCapInterestRate	0.08	pure
CY2021Q1	us-gaap	Equipment Expense EquipmentExpense	9733	usd
CY2021Q1	us-gaap	Derivative Average Cap Interest Rate DerivativeAverageCapInterestRate	0.08	pure
CY2021Q1	us-gaap	Equipment Expense EquipmentExpense	37171	usd
	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	500	shares
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	321000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	267500	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	321000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	214000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107000	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26750	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26750	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	53500	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	53500	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0825	pure
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0825	pure
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	300000	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	1221	usd
CY2020Q3	us-gaap	Taxes And Licenses TaxesAndLicenses	455000	usd
CY2022Q1	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	175000	usd
CY2018	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	70000	usd
CY2019Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	60000	usd
	us-gaap	Product Liability Contingency Third Party Recovery Percentage ProductLiabilityContingencyThirdPartyRecoveryPercentage	0.0075	pure
CY2023Q1	adtx	Gross Proceeds GrossProceeds	1500000	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	75000	usd
CY2023Q2	adtx	Gross Proceeds GrossProceeds	2000000	usd
CY2023Q2	adtx	Future Receipts Agreement FutureReceiptsAgreement	1157143	usd
CY2023Q2	adtx	Net Proceeds NetProceeds	742857	usd
CY2023Q2	adtx	Principal Amount PrincipalAmount	1060000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	60000	usd
CY2023Q2	adtx	Business Loan And Security Agreement BusinessLoanAndSecurityAgreement	(i) $1,000,000 if paid prior to April 6, 2023, (ii) $1,219,000 if paid prior to April 10, 2023, or (iii) $1,590,000 if paid after April 10, 2023 and will be repaid in 20 weekly installments of $79,500 commencing on April 10, 2023 and ending on August 21, 2023.
CY2023Q2	adtx	Net Proceeds NetProceeds	860500	usd
CY2023Q2	adtx	Principal Amount PrincipalAmount	1060000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	60000	usd
CY2023Q2	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	1590000	usd
CY2023Q2	adtx	Installment Due Amount InstallmentDueAmount	79500	usd
CY2023Q2	adtx	Principal Amount PrincipalAmount	2000000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	100000	usd
CY2023Q2	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	2880000	usd
CY2023Q2	adtx	Installment Due Amount InstallmentDueAmount	102857	usd
	adtx	Principal Amount PrincipalAmount	1951366	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	85714	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	281000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	596560	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	653408	usd
	us-gaap	Lease Cost LeaseCost	596560	usd
	us-gaap	Lease Cost LeaseCost	653408	usd
	adtx	Expiration Period ExpirationPeriod	P3Y
CY2022Q1	srt	Extensions Discoveries Additions And Improved Recovery Less Related Costs ExtensionsDiscoveriesAdditionsAndImprovedRecoveryLessRelatedCosts	100000	usd
CY2020Q1	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	25000	usd
CY2023Q2	adtx	Right Of Use Asset Short Term RightOfUseAssetShortTerm	2701338	usd
CY2022Q4	adtx	Right Of Use Asset Short Term RightOfUseAssetShortTerm	3160457	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2701338	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3160457	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1102779	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1086658	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1419257	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1885218	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2522036	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2971876	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M14D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	570629	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1004982	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	710546	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	423930	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2710087	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	188051	usd
CY2023Q2	adtx	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	1102779	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1419257	usd
CY2018Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	10000	shares
CY2018Q1	adtx	Expiration Date ExpirationDate	2023-03-08
	us-gaap	Broadcasters License Agreement Commitments Description BroadcastersLicenseAgreementCommitmentsDescription	In addition to the annual license maintenance fees outlined above, we will pay Stanford royalties on Net Sales (as such term is defined in the February 2020 License Agreement) during the of the term of the agreement as follows: 4% when Net Sales are below or equal to $5 million annually or 6% when Net Sales are above $5 million annually.
CY2023Q2	adtx	Asset Purchase Agreement AssetPurchaseAgreement	24500000	usd
CY2023Q2	us-gaap	Loans Payable LoansPayable	14500000	usd
CY2023Q2	us-gaap	Cash Cash	10000000	usd
CY2023Q2	adtx	Payments Term PaymentsTerm	P7Y
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.50	pure
	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	1800000	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On September 13, 2022, the Company effectuated a 1 for 50 reverse stock split (the “Reverse Split”).
	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	187000	shares
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	168300	usd
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11644	shares
CY2022Q4	adtx	Aggregate Shares Price AggregateSharesPrice	50000000	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	338513	shares
	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1.55
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	507016	usd
CY2023Q2	adtx	Preferred Stock Par Value PreferredStockParValue	0.001
CY2022Q3	adtx	Shares Of Common Stock SharesOfCommonStock	1	shares
CY2022Q3	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	20000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250000000	shares
	us-gaap	Redemption Premium RedemptionPremium	20000	usd
CY2022Q4	adtx	Company Paid CompanyPaid	20000	usd
CY2022Q4	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	1	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	60000	shares
CY2021Q1	adtx	Fair Market Value FairMarketValue	1	pure
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	44037	shares
	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	171.13
	adtx	Share Based Payment Remnaining Expenses ShareBasedPaymentRemnainingExpenses	59964	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P0Y3M
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	267318	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	557223	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q2	adtx	Warrant Purchase Price WarrantPurchasePrice	1.219
CY2023Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1600000	usd
CY2023Q2	us-gaap	Payments For Commissions PaymentsForCommissions	291000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.86
CY2023Q2	adtx	Exercisable Period ExercisablePeriod	P3Y
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	95121	shares
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.525
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	214451	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	687375	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	5035	usd
	adtx	Rs Us Vested RSUsVested	3400	shares
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	3400	shares
CY2023Q2	adtx	Shares Of Common Stockvested Rs Us SharesOfCommonStockvestedRSUs	3400	shares
CY2023Q3	adtx	Maturity Date MaturityDate	2023-12-31
CY2023Q3	adtx	Maturity Date MaturityDate	2023-12-31
CY2023Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1000	usd
CY2022Q4	adtx	Notes Payable Net Of Discount NotesPayableNetOfDiscount		usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
	us-gaap	Other Income OtherIncome		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.21
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.18
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5374826	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6177857	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	901468	shares
CY2023Q2	adtx	Exercise Of Warrants ExerciseOfWarrants		usd
CY2022Q2	adtx	Issuance Of Restricted Stock Units For Compensation IssuanceOfRestrictedStockUnitsForCompensation		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	adtx	Discount On Note Payable From Offering Costs DiscountOnNotePayableFromOfferingCosts		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001726711

Files In Submission

Name	View Source	Status
0001213900-23-067112-index-headers.html	Edgar Link	pending
0001213900-23-067112-index.html	Edgar Link	pending
0001213900-23-067112.txt	Edgar Link	pending
0001213900-23-067112-xbrl.zip	Edgar Link	pending
adtx-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_aditxt.htm	Edgar Link	pending
f10q0623ex31-2_aditxt.htm	Edgar Link	pending
f10q0623ex32-1_aditxt.htm	Edgar Link	pending
f10q0623_aditxt.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
adtx-20230630_cal.xml	Edgar Link	unprocessable
adtx-20230630_lab.xml	Edgar Link	unprocessable
adtx-20230630_def.xml	Edgar Link	unprocessable
adtx-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_aditxt_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADTX
Aditxt, Inc. Stock $adtx

2023 Q3 Form 10-Q Financial Statement

#000121390023067112 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX Aditxt, Inc. Stock $adtx

2023 Q3 Form 10-Q Financial Statement

#000121390023067112 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX
Aditxt, Inc. Stock $adtx